Catherine C. L. Wong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Catherine C. L. Wong has a total of 991 co-authors. Here are the top co-authors by number of shared publications:
John R. Yates
The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA
17 shared publicationsShuaixin Gao
Department of Medical Research Center, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), 100730 Beijing, China; Tsinghua University-Peking University Joint Center for Life Sciences, Tsinghua University, 100084 Beijing, China
15 shared publicationsMin Huang
State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China
10 shared publicationsTao Xu
The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA
10 shared publicationsNan Zhang
Center for Precision Medicine Multi-Omics Research, Peking University Health Science Center, Peking University, Beijing 100191, China
9 shared publicationsSiyuan Wang
State Key Laboratory for Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China
8 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Springer Nature in Research Square
Phosphatidylethanolamine lipids secreted by CD8⁺ T cells mediate cytotoxic immunity
Current understanding of T-cell immunity largely focuses on protein factors responsible for immune surveillance and regulation, with limited exploration of the roles played by other molecular types. While proteins such as perforin and granzymes are well-established mediators of CD8⁺ T cell cytotoxicity 1-5 , our study uncovers the cone-shaped phosphatidylethanolamine (PE) lipids as a new class of effector molecules with broad cytotoxic functions against tumor and infected cells. Upon activation, CD8⁺ T cells upregulated the de novo biosynthesis pathway to produce substantial amounts of PE lipids carrying polyunsaturated or monounsaturated fatty acid sidechains. The newly synthesized PE lipids were packaged into vesicular compartments distinct from Lamp1⁺ granules, rapidly polarized to immunological synapses, and secreted through the membrane fusion protein Munc13-4, generating PE⁺ extracellular vesicles enriched in synaptic lipids and proteins. CD8-derived PE lipids were efficiently taken up by target cells and transported to the endoplasmic reticulum via Esyt1, where excessive PE loading induced ER stress and triggered Chop-dependent cell death within a few hours. The PE pathway functioned independently of conventional cytotoxic mechanisms and remained effective even when those pathways were absent. Manipulation of the PE-Esyt1-ER stress axis markedly altered T cell cytotoxicity, and ethanolamine pretreatment of T cells enhanced the efficacy of adoptive cell therapy. These findings introduce a new lipid-based mechanism of cytotoxic immunity and underscore the importance of non-protein molecules as immune effectors.
- 3 November 2026
- Published by Springer Nature in Research Square
Open AccessPhosphatidylethanolamine lipids secreted by CD8⁺ T cells mediate cytotoxic immunity
Current understanding of T-cell immunity largely focuses on protein factors responsible for immune surveillance and regulation, with limited exploration of the roles played by other molecular types. While proteins such as perforin and granzymes are well-established mediators of CD8⁺ T cell cytotoxicity 1-5 , our study uncovers the cone-shaped phosphatidylethanolamine (PE) lipids as a new class of effector molecules with broad cytotoxic functions against tumor and infected cells. Upon activation, CD8⁺ T cells upregulated the de novo biosynthesis pathway to produce substantial amounts of PE lipids carrying polyunsaturated or monounsaturated fatty acid sidechains. The newly synthesized PE lipids were packaged into vesicular compartments distinct from Lamp1⁺ granules, rapidly polarized to immunological synapses, and secreted through the membrane fusion protein Munc13-4, generating PE⁺ extracellular vesicles enriched in synaptic lipids and proteins. CD8-derived PE lipids were efficiently taken up by target cells and transported to the endoplasmic reticulum via Esyt1, where excessive PE loading induced ER stress and triggered Chop-dependent cell death within a few hours. The PE pathway functioned independently of conventional cytotoxic mechanisms and remained effective even when those pathways were absent. Manipulation of the PE-Esyt1-ER stress axis markedly altered T cell cytotoxicity, and ethanolamine pretreatment of T cells enhanced the efficacy of adoptive cell therapy. These findings introduce a new lipid-based mechanism of cytotoxic immunity and underscore the importance of non-protein molecules as immune effectors.
- Open Access
- 8 September 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (37) , 40579
Correction to “Protein Tyrosine Amination: Detection, Imaging, and Chemoproteomic Profiling with Synthetic Probes”
- 8 September 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (37) , 40579
Open AccessCorrection to “Protein Tyrosine Amination: Detection, Imaging, and Chemoproteomic Profiling with Synthetic Probes”
- 1 September 2026
- Published by Springer Nature in Science China Life Sciences
- p. 1-4
Nusap-dependent inhibition of Separase in meiosis
- 1 September 2026
- Published by Springer Nature in Science China Life Sciences
- p. 1-4
Nusap-dependent inhibition of Separase in meiosis
- Open Access
- 10 August 2026
- Published by Springer Nature in Nature
- Vol. 656 (8129) , E46
Author Correction: Nucleolar URB1 ensures 3′ ETS rRNA removal to prevent exosome surveillance
- 10 August 2026
- Published by Springer Nature in Nature
- Vol. 656 (8129) , E46
Open AccessAuthor Correction: Nucleolar URB1 ensures 3′ ETS rRNA removal to prevent exosome surveillance
- Open Access
- 4 August 2026
- Published by Elsevier in SSRN Electronic Journal
Machine Learning-Guided Serum Ion Mobility Fingerprinting for Real-Time Rheumatoid Arthritis (RA) Screening
Background: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that causes substantial disability worldwide. Early recognition of RA is critical to prevent irreversible joint damage and improve long-term prognosis. However, current diagnostic strategies rely largely on individual serological biomarkers, primarily anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF), which fail to identify 20–40% of patients with RA. We therefore sought to develop a robust serum molecular fingerprinting strategy using miniaturized ion mobility spectrometry (IMS) coupled with machine learning for RA screening and to explore the molecular basis of the discriminatory fingerprints using tandem mass spectrometry (MS).Methods: We recruited a total of 321 participants, including 100 patients with RA (age range: 49–65 years; mean: 62.6; SD: 2.0), 100 with osteoarthritis (OA; age range: 40–85 years; mean: 61.5; SD: 9.5), 10 with systemic lupus erythematosus (SLE; age range: 48–68 years; mean: 60.4; SD: 6.7), 11 with Sjögren's syndrome (SS; age range: 49–69 years; mean: 60.4; SD: 6.1), and 100 healthy controls (HC; age range: 44–65 years; mean: 59.6; SD: 5.4) for RA-specific pattern profiling and validation. Serum samples (20 μL) were processed using a high-throughput preparation workflow and analyzed with a direct-spray miniaturized IMS platform to rapidly generate serum molecular fingerprints. Machine learning algorithms, including regularized logistic regression (RLR) and multilayer perceptron (MLP) models, were used to identify characteristic IMS-derived features and distinguish RA-specific molecular patterns from non-RA groups. Diagnostic performance was assessed by receiver operating characteristic (ROC) analysis, including sensitivity, specificity, accuracy, positive predictive value (PPV), negative predictive value (NPV), and F1 score. High-resolution trapped ion mobility spectrometry time-of-flight mass spectrometry (tIMS-TOF/MS) and de novo proteome analysis were used to determine the molecular composition and biological pathways underlying the discriminatory fingerprints.Findings: IMS-derived serum fingerprints showed distinct clustering of RA, OA, and HC samples, with high intragroup similarity and clear intergroup separation. Twenty standardized drift-time peaks ranging from 5.58 ms to 21.48 ms were retained as fingerprint features following integration of the RLR and MLP models, of which eight peaks were the principal contributors to RA discrimination. In validation analyses, the IMS-based model achieved excellent discrimination of RA from OA and HC, with an area under the ROC curve (AUC) of 1.0000 for both comparisons. Although discrimination between RA and SLE or SS was lower than for OA and healthy controls, the model maintained informative diagnostic performance, with AUCs of 0.7471 and 0.8222, respectively. For RA versus the combined non-RA group, the model achieved an overall AUC of 0.9995, with an accuracy of 0.969, sensitivity of 0.927, specificity of 0.986, PPV of 0.967, NPV of 0.969, and an F1 score of 0.947, indicating strong diagnostic capability for RA. High-resolution tIMS-TOF/MS identified the molecular composition underlying the discriminatory IMS fingerprints, including immunopeptides, bile acids, and lipid species, while de novo peptide sequencing and proteome profiling showed that these molecular signatures converged on immune regulation, inflammatory responses, complement and coagulation cascades, and lipid metabolic pathways, providing biological interpretation of the RA-associated serum fingerprints.Interpretation: The machine learning-guided miniaturized IMS platform enables rapid and accurate discrimination of RA from non-RA groups (OA, SS, SLE, and HC) by capturing multidimensional serum molecular fingerprints rather than relying on a single biomarker. In addition to its excellent diagnostic performance, high-resolution molecular annotation provides biological interpretability and suggests that these characteristic signatures reflect coordinated alterations across proteins, peptides, lipids, and metabolites. Together, these features make this strategy well suited for clinical translation, with the potential to facilitate rapid molecular triage in routine rheumatology practice.
- 4 August 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessMachine Learning-Guided Serum Ion Mobility Fingerprinting for Real-Time Rheumatoid Arthritis (RA) Screening
Background: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that causes substantial disability worldwide. Early recognition of RA is critical to prevent irreversible joint damage and improve long-term prognosis. However, current diagnostic strategies rely largely on individual serological biomarkers, primarily anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF), which fail to identify 20–40% of patients with RA. We therefore sought to develop a robust serum molecular fingerprinting strategy using miniaturized ion mobility spectrometry (IMS) coupled with machine learning for RA screening and to explore the molecular basis of the discriminatory fingerprints using tandem mass spectrometry (MS).Methods: We recruited a total of 321 participants, including 100 patients with RA (age range: 49–65 years; mean: 62.6; SD: 2.0), 100 with osteoarthritis (OA; age range: 40–85 years; mean: 61.5; SD: 9.5), 10 with systemic lupus erythematosus (SLE; age range: 48–68 years; mean: 60.4; SD: 6.7), 11 with Sjögren's syndrome (SS; age range: 49–69 years; mean: 60.4; SD: 6.1), and 100 healthy controls (HC; age range: 44–65 years; mean: 59.6; SD: 5.4) for RA-specific pattern profiling and validation. Serum samples (20 μL) were processed using a high-throughput preparation workflow and analyzed with a direct-spray miniaturized IMS platform to rapidly generate serum molecular fingerprints. Machine learning algorithms, including regularized logistic regression (RLR) and multilayer perceptron (MLP) models, were used to identify characteristic IMS-derived features and distinguish RA-specific molecular patterns from non-RA groups. Diagnostic performance was assessed by receiver operating characteristic (ROC) analysis, including sensitivity, specificity, accuracy, positive predictive value (PPV), negative predictive value (NPV), and F1 score. High-resolution trapped ion mobility spectrometry time-of-flight mass spectrometry (tIMS-TOF/MS) and de novo proteome analysis were used to determine the molecular composition and biological pathways underlying the discriminatory fingerprints.Findings: IMS-derived serum fingerprints showed distinct clustering of RA, OA, and HC samples, with high intragroup similarity and clear intergroup separation. Twenty standardized drift-time peaks ranging from 5.58 ms to 21.48 ms were retained as fingerprint features following integration of the RLR and MLP models, of which eight peaks were the principal contributors to RA discrimination. In validation analyses, the IMS-based model achieved excellent discrimination of RA from OA and HC, with an area under the ROC curve (AUC) of 1.0000 for both comparisons. Although discrimination between RA and SLE or SS was lower than for OA and healthy controls, the model maintained informative diagnostic performance, with AUCs of 0.7471 and 0.8222, respectively. For RA versus the combined non-RA group, the model achieved an overall AUC of 0.9995, with an accuracy of 0.969, sensitivity of 0.927, specificity of 0.986, PPV of 0.967, NPV of 0.969, and an F1 score of 0.947, indicating strong diagnostic capability for RA. High-resolution tIMS-TOF/MS identified the molecular composition underlying the discriminatory IMS fingerprints, including immunopeptides, bile acids, and lipid species, while de novo peptide sequencing and proteome profiling showed that these molecular signatures converged on immune regulation, inflammatory responses, complement and coagulation cascades, and lipid metabolic pathways, providing biological interpretation of the RA-associated serum fingerprints.Interpretation: The machine learning-guided miniaturized IMS platform enables rapid and accurate discrimination of RA from non-RA groups (OA, SS, SLE, and HC) by capturing multidimensional serum molecular fingerprints rather than relying on a single biomarker. In addition to its excellent diagnostic performance, high-resolution molecular annotation provides biological interpretability and suggests that these characteristic signatures reflect coordinated alterations across proteins, peptides, lipids, and metabolites. Together, these features make this strategy well suited for clinical translation, with the potential to facilitate rapid molecular triage in routine rheumatology practice.
- Open Access
- 14 November 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (46)
mTORC1 regulates autophagosomal components recycling through SNX16 phosphorylation
During autophagy, the contents enclosed within autophagosomes are degraded, while the outer membrane components are recycled from autolysosomes by the recycler complex through the recently discovered autophagosomal components recycling (ACR) process. This recycling is essential for maintaining autophagic activity. However, the molecular machinery and upstream regulatory mechanisms driving this recycling process remain poorly understood. Here, we identify SNX16 as a key component of the recycler complex, which localizes to autolysosomes and is required for ACR. SNX16 functions in ACR by regulating recycler complex formation, facilitating cargo recognition, and mediating the connection between STX17–SNX4–SNX5 and dynein–dynactin complexes. In addition, SNX16–cargo interactions are regulated by two ACR-related small GTPases, Rab32 and Rab38. Importantly, mTORC1 phosphorylates SNX16 to regulate ACR by inhibiting its interactions with STX17 and other recycler components, thus preventing recycler complex formation. Taken together, our findings identify SNX16 as a recycler component and establish a link between mTORC1 and ACR.
- 14 November 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (46)
Open AccessmTORC1 regulates autophagosomal components recycling through SNX16 phosphorylation
During autophagy, the contents enclosed within autophagosomes are degraded, while the outer membrane components are recycled from autolysosomes by the recycler complex through the recently discovered autophagosomal components recycling (ACR) process. This recycling is essential for maintaining autophagic activity. However, the molecular machinery and upstream regulatory mechanisms driving this recycling process remain poorly understood. Here, we identify SNX16 as a key component of the recycler complex, which localizes to autolysosomes and is required for ACR. SNX16 functions in ACR by regulating recycler complex formation, facilitating cargo recognition, and mediating the connection between STX17–SNX4–SNX5 and dynein–dynactin complexes. In addition, SNX16–cargo interactions are regulated by two ACR-related small GTPases, Rab32 and Rab38. Importantly, mTORC1 phosphorylates SNX16 to regulate ACR by inhibiting its interactions with STX17 and other recycler components, thus preventing recycler complex formation. Taken together, our findings identify SNX16 as a recycler component and establish a link between mTORC1 and ACR.
- Open Access
- 14 October 2025
- Published by Springer Nature in Immunity & Inflammation
- Vol. 1 (1) , 7
Peripheral immune signatures and immune-axonal regulatory axis in amyotrophic lateral sclerosis: implications for disease pathogenesis and therapeutic targeting
- 14 October 2025
- Published by Springer Nature in Immunity & Inflammation
- Vol. 1 (1) , 7
Open AccessPeripheral immune signatures and immune-axonal regulatory axis in amyotrophic lateral sclerosis: implications for disease pathogenesis and therapeutic targeting
- 11 August 2025
- Published by Elsevier in Science Bulletin
- Vol. 71 (2) , 278-282
Unique plasma proteome signatures differentiate adolescent major depressive disorder, bipolar disorder and schizophrenia
- 11 August 2025
- Published by Elsevier in Science Bulletin
- Vol. 71 (2) , 278-282
Unique plasma proteome signatures differentiate adolescent major depressive disorder, bipolar disorder and schizophrenia
- Open Access
- 30 July 2025
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 82 (1) , 1-20
Proteome of oocyte spindle identifies Ccdc69 regulates spindle assembly like “band-tightening spell”
Meiotic spindle is an intricate structure and required for chromosome segregation and the proper meiotic progression during oocyte maturation, and its function is regulated by a complex network of proteins located at spindle and its peripheral region. However, proteome of meiotic spindle remains poorly characterized. Here, we acquired the proteomic profile of spindles isolated from metaphase I (MI) and metaphase II (MII) mouse oocytes. In particular, we identified Ccdc69 as a novel regulator of spindle assembly in mouse oocytes. Although deletion of Ccdc69 did not affect female fertility, the MI spindles were elongated in Ccdc69 knockout oocytes. Overexpression of Ccdc69 induced spindle defects by reducing microtubule formation and disturbing acentriolar microtubule organization centers (aMTOCs) distribution. Furthermore, Ccdc69 overexpression impaired kinetochore-microtubule (K-MT) attachment and delayed meiotic progression by abnormal activation of spindle assembly checkpoint (SAC). Taken together, our study depicts the proteome of spindles during mouse oocyte maturation and demonstrates that Ccdc69 regulates spindle assembly and meiotic progression the way similar to “The Tightening Spell of Sun Wukong’s Golden Headband” in the famous Chinese Classic Journey to the West.
- 30 July 2025
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 82 (1) , 1-20
Open AccessProteome of oocyte spindle identifies Ccdc69 regulates spindle assembly like “band-tightening spell”
Meiotic spindle is an intricate structure and required for chromosome segregation and the proper meiotic progression during oocyte maturation, and its function is regulated by a complex network of proteins located at spindle and its peripheral region. However, proteome of meiotic spindle remains poorly characterized. Here, we acquired the proteomic profile of spindles isolated from metaphase I (MI) and metaphase II (MII) mouse oocytes. In particular, we identified Ccdc69 as a novel regulator of spindle assembly in mouse oocytes. Although deletion of Ccdc69 did not affect female fertility, the MI spindles were elongated in Ccdc69 knockout oocytes. Overexpression of Ccdc69 induced spindle defects by reducing microtubule formation and disturbing acentriolar microtubule organization centers (aMTOCs) distribution. Furthermore, Ccdc69 overexpression impaired kinetochore-microtubule (K-MT) attachment and delayed meiotic progression by abnormal activation of spindle assembly checkpoint (SAC). Taken together, our study depicts the proteome of spindles during mouse oocyte maturation and demonstrates that Ccdc69 regulates spindle assembly and meiotic progression the way similar to “The Tightening Spell of Sun Wukong’s Golden Headband” in the famous Chinese Classic Journey to the West.
- Open Access
- 17 February 2025
- Published by Elsevier in Cellular Signalling
- Vol. 129, 111671
Lung cancer associated transcript 1 binds heat shock protein 90 to promote growth of hepatocellular carcinoma
- 17 February 2025
- Published by Elsevier in Cellular Signalling
- Vol. 129, 111671
Open AccessLung cancer associated transcript 1 binds heat shock protein 90 to promote growth of hepatocellular carcinoma